BRCA2

Dec 16, 2019

Ambry Genetics Receives New York State Approval to Offer Paired RNA and DNA Genetic Testing for Hereditary Cancer Risk

Oct 01, 2019

Ambry Genetics Makes Scientific Breakthrough and Launches Paired RNA and DNA Testing for Hereditary Cancer

Aug 27, 2019

Ambry Genetics' Data Reveal that Expanding Genetic Testing Guidelines Could Identify More Patients with Increased Risks of Cancer

Mar 25, 2019

Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer

Dec 10, 2018

New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients

Mar 07, 2018

Assemblywomen Autumn Burke and Marie Waldron Demand More Genetic Testing for Women with a High Risk of Ovarian and Breast Cancer

Mar 06, 2018

FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

Dec 05, 2017

Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families

Jun 05, 2017

Caris Life Sciences' Molecular Intelligence Platform Measures Prevalence of Oncogenic Homologous Recombination Pathway Mutations across 53,000 Tumors